Schedule 13D ownership disclosure

MERUS N V

Common Shares, Euro 0.09 nominal value per share · CUSIP: N5749R100

Event date: 2025-12-12

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Genmab A/SReported CIK 0001434265

    Shares: 71,946,801 · Class: 94.8%

  • Genmab Holding II B.V.

    Shares: 71,946,801 · Class: 94.8%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-25-326263
Form type
SCHEDULE 13D
Filer
GENMAB A/S
CIK
CIK 1434265
Filed
Dec 19, 2025
Reporting period
Dec 12, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub